One-stage lengthening of femoral nonunion augmented with human bone morphogenetic protein

Clinical Orthopaedics and Related Research

Volumn 347, Issue , 1998, Pages 105-116

  Johnson, Eric E ^a   Urist, Marshall R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; BONE GRAFT; BONE PLATE; BONE REMODELING; BONE SCREW; CLINICAL ARTICLE; FEMALE; FEMUR FRACTURE; FRACTURE FIXATION; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; LEG LENGTH INEQUALITY; MALE; OSTEOSYNTHESIS; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 0031936107     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199802000-00013     Document Type: Article

References (79)

1. Amstutz HC: One stage femoral lengthening. J Hosp Special Surg 1:57-64, 1975.
2. An J, Rosen V, Cox K, Beauchemin N, Sullivan AK: Recombinant human bone morphogenetic protein-2 induces a hematopoietic microenvironment in the rat that supports the growth of stem cells. Exp Hematol 24:768-775, 1996.
3. Armour PC, Scott JH: Equalization of leg length. J Bone Joint Surg 638:587-592, 1981.
4. Aspenberg P, Turek T: BMP-2 for intramuscular bone induction: Effect in squirrel monkeys is dependent on implantation site. Acta Orthop Scand 67:3-6, 1996.
5. Aspenberg P, Wang E, Throngren KG: Bone morphogenetic protein induces bone in the squirrel monkey but bone matrix does not. Acta Orthop Scand 63:619-622, 1992.
6. Bjerkreim I, Helium C: Femur lengthening using the Wagner technique. Acta Orthop Scand 54:263-236, 1983. ;
7. Bost FC, Larsen IJ: Experiences with lengthening of the femur over an intramedullary rod. J Bone Joint Surg 38A:567-584, 1956.
8. Bostrom M, Lane JM, Tomin E, et al: Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop 327:272-282, 1996.
9. Cauchoix J: One stage femoral lengthening. An important step in the management of lower limb discrepancy. J Bone Joint Surg 54A: 1802-1803, 1971.
10. Cauchoix J, Morel G: One stage femoral lengthening. Clin Orthop 136:66-73, 1978.
11. Cattaneo, R, Catagni M, Johnson EE: The treatment of infected nonunions and segmental defects of the tibia by the methods of llizarov. Clin Orthop 280:143-152, 1992.
12. Chandler D, King JD, Bernstein SM, et al: Results of 21 Wagner limb lengthenings in 20 patients. Clin Orthop 230:214-222, 1988.
13. Chen D, Feng JQ, Feng M, et al: Sequence and expression of bone morphogenetic protein 3 mRNA in prolonged cultures of fetal rat calvarial osteoblasts and in rat prostate adenocarcinoma PA HI cells. DNACellBiol 14:235-239,1995.
14. Chen P, Carrington JL, Hammonds RG, Reddi AH: Stimulation of chondrogenesis in limb bud cells by recombinant human bone morphogenetic protein 2B (BMP-2B) and modulation by transforming growth factor beta 1 and beta 2. Exp Cell Res 195:509-515, 1991.
15. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC: Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmentai defect. Clin Orthop 301:302-312,1994.
16. Dudley AT, Lyons KM, Robertson EJ: A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795-2807, 1995.
17. Fainsod A, Steinbeidder H, De Robertis EM: On the function of BMP-4 in patterning the marginal zone of the Xenopus embryo. EMBO J 13:5015-5025, 1994.
18. Ferguson D, Davis WL, Urist MR, Hurt WC, Allen EP: Bovine bone morphogenetic protein (bBMP) fraction-induced repair of craniotomy defects in the rhesus monkey (Macaca speciosa). Clin Orthop 219:251-258, 1987.
19. Friedlaender GE: Current concepts review: Bone grafts: The basic scientific rational for clinical application. J Bone Joint Surg 69A:786-790, 1987.
20. Garcia-Cimbrelo E, Olsen B, Ruiz-Yague M, Fernandez-Baillo N, Munuera-Martinez L: llizarov technique. Results and difficulties. Clin Orthop 283:116-123,1992.
21. Gerhart TN, Kirker-Head CA, Kriz MJ, et al: Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 293:317-326, 1993.
22. Green SA, Jackson JM, Wall DM, Marinow H, Ishkanian J: Management of segmental defects by the llizarov intercalary bone transport method. Clin Orthop 280:136-142, 1992.
23. Guarniero R, Barros JrTEP: Femoral lengthening by the Wagner method. Clin Orthop 250:154-159, 1990.
24. Heckman JD, Boyan BD, Aufdemorte TB, Abbott JT: The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg 73A:750-764, 1991.
25. Herron LD, Amstutz HC, Sakai DN: One stage femoral lengthening in the adult. Clin Orthop 136:74-82,1978.
26. Hood RW, Riseborough EJ: lengthening of the lower extremity by the Wagner method. A review of the Boston Children's Hospital experience. J Bone Joint Surg 63A:1122-1131, 1981.
27. Hughes FJ, CoIIyer J, Standfield M, Goodman SA: The effects of bone morphogenetic protein-2, -4, -6 on differential of rat osteoblast cells in vitro. Endocrinology 136:2671-2677,1995.
28. Johnson EE: Acute lengthening of shortened lower extremities following malunion, or nonunion of fracture. J Bone Joint Surg 76A:379-389,1994.
29. Johnson EE, Urist MR, Finerman GAM: Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. Clin Orthop 236:249-257, 1988.
30. Johnson EE, Urist MR, Finerman GAM: Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. Clin Orthop 230:257-265, 1988.
31. Johnson EE, Urist MR, Finerman GAM: Distal metaphyseal tibial nonunion: Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP). Clin Orthop 250:234-240, 1990.
32. Johnson EE, Urist MR, Finerman GAM: Resistant nonunions and partial or complete segmental defects of long bones: Results of treatment with composite human bone morphogenetic protein (hBMP/AAA) grafting. Clin Orthop 277:229-237, 1992.
33. Kempf I, Grosse A, Abalo C: Locked intramedullary nailing. Its application to femoral and tibial axial, rotational, lengthening, and shortening osteotomies. Clin Orthop 212:165-173, 1986.
34. Kirker-Head CA, Gerhart TN, Schelling SH, et al: Long term healing of bone using recombinant human bone morphogenetic protein 2. Clin Orthop 318:222-230, 1995.
35. Kitaoka H, Urist MR: Transplant of bone marrow and muscle derived connective tissue cultures in diffusion chambers for bioassay of bone morphogenetic protein. Clin Orthop 286:262-270, 1993.
36. Kratochwill K, Dull M, Farinas I, Galceran J, Grosschedl R: Lef 1 expression is activated by BMP-4 and regulates inductive tissue interactions in tooth and hair development. Genes Dev 10:1382-1394, 1996.
37. Liem KF, Tremmi G, Roelink H, Jessell TM: Dorsal differentiation of neural plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell 82:969-979,1995.
38. Lindholm TC, Lindholm TS, Marttinen A, Urist MR: Bovine bone morphogenetic protein (bBMP/ NCP)-induced repair of skull trephine defects in pigs. Clin Orthop 301:263-270, 1994.
39. Lovell TP, Dawson EG, Nilsson OS, Urist MR: Augmentation of spinal fusion with bone morphogenetic protein in dogs. Clin Orthop 243:266-274, 1989.
40. Luo G, Hofmann C, Bronckers AL, et al: BMP-7 is an inducer of nephrogenesis and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820, 1995. ;
41. Manning C: Leg lengthening. Clin Orthop 136: 105-110,1978. :
42. McCarroll HR: Trials and tribulations in attempted femoral lengthening. J Bone Joint Surg 32A: 132-142, 1950.
43. D'Aubigné Merle R, Dubosset J: Surgical correction of large length discrepancies in the lower extremities of children and adults. J Bone Joint Surg 53A: 411-430,1971.
44. Mishina Y, Suzuki A, Ueno N, Behringer RR: Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 9:3027-3037, 1995.
45. Mitzutani H, Urist MR: The nature of bone morphogenetic protein (BMP) fractions derived from bovine bone matrix gelatin. Clin Orthop 171:213-223, 1982.
46. Moseley CF: Leg lengthening. A review of 30 years. Clin Orthop 247:38-43,1989.
47. Muschler GF, Hyodo A, Manning T, Kambic H, Easley K: Evaluation of human bone morphogenetic protein 2 in canine spinal fusion model. Clin Orthop 308:229-240,1994.
48. Nakahara H, Takaoka K, Koezuka M, et al: Periosteal bone formation elicited by partially purified bone morphogenetic protein. Clin Orthop 239: 299-305,1989.
49. Nilsson O, Urist MR: Response of the rabbit metaphysis to implants of bone morphogenetic protein (bBMP) Clin Orthop 195:275-281, 1985.
50. Nilsson OS, Urist MR, Davvson EG, Schmalzried TP, Finerman GAM: Bone repair induced by bone morphogenetic protein in ulnar defects in dogs. J Bone Joint Surg 68B:635-642, 1986.
51. Paley D: Problems, obstacles, and complications of limb lengthening by the Ilizarov technique. Clin Orthop 250:81-104, 1990.
52. Paley D, Catagni MA, Argnani F, et al: Ilizarov treatment of tibial nonunions with bone loss. Clin Orthop 241:146-165,1989.
53. Paley D, Chaudray M, Pirone AM, Lentz P, Kautz D: Treatment of malunions and mal-nonunions of the femur and tibia by detailed preoperative planning and the Ilizarov technique. Orthop Clin North Am 21:667-691,1990.
54. Paterson D: Leg-lengthening procedures. A historical review. Clin Orthop 250:27-33, 1990.
55. Rosen V, Theis RS, Lyons K: Signaling pathways in skeletal development: a role for BMP receptors. Ann NY Acad Sei 785:318-320,1996.
56. Sakano S, Murata Y, Miura T, et al: Collagen and alkaline phosphatase gene expression during bone morphogenetic protein (BMP)-induced cartilage and bone differentiation. Clin Orthop 292:337-344, 1993.
57. Sato K, Urist MR: Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. Clin Orthop 187:301-311, 1985.
58. Schelling SH, Wang E: Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 293:317-326, 1993.
59. Shimell MJ, Ferguson EL, Childs SR, O'Connell MB: The Drosophila dorsal-ventral patterning of gene tolloid is related to human bone morphogenetic protein 1. Cell 67:469-481, 1991.
60. Shimizu K, Yoshikawa H, Takaoka K: Local effects of bone morphogenetic protein-4 on skeletal tissues. Clin Orthop 318:243-250,1995.
61. Song JJ, Celeste AJ, Kong FM, et al: Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 136:4293-297, 1995.
62. Steibeisser H, Fainsod A, Niehrs C, Sasai Y, De Robertis EM: The role of gsc and BMP-4 in dorsalventral patterning of the marginal zone in Xenopus: A loss of function study using antisense RNA. EMBOJ 14:5230-5243, 1995.
63. Stevenson S, Cunningham N, Toth J, Davy D, Reddi AH: The effect of osteogenin (a bone morpho-genetic protein) on the formation of bone in orthotopic segmental defects in rats. J Bone Joint Surg 76A: 1676-1687,1994.
64. Takagi K, Urist MR: The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 196:100-109, 1982.
65. Takaoka K, Yoshikawa H, Hasimoto J, et al: Gene cloning and expression of a bone morphogenetic protein derived from a murine sarcoma. Clin Orthop 294:344-352, 1993.
66. Thies RS, Bauduy M, Ashton BA, et al: Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130:1318-1324, 1992.
67. Urist MR: Emerging Concepts of Bone Morphogenetic Protein: The Fundamentals of Bone Growth. In Dixon A, Sarnat B (eds). Third International Conference. Caldwell, Telford Press, 189-198, 1990.
68. Urist MR, DeLange RJ, Finerman GAM: Bone cell differentiation and growth factors. Science 220: 680-686,1983.
69. Urist MR, Hudak RT: Radioimmune assay of bone morphogenetic protein in serum: A tissue-specific parameter of bone metabolism. Proc Soc Exp Biol Med 176:472-475, 1984.
70. Urist MR, Huo YK, Brownell AG, et al: Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sei USA 81:371-375, 1984.
71. Urist MR, Mikulski A, Boyd SD: A chemosterilized antigen-extracted autodigested alloimplant for bone banks. Arch Surg 110:416,1975.
72. Urist MR, Nilsson OS, Hudak R, et al: Immunologie evidence of a bone morphogenetic protein in the milieu inteur. Ann Biol Clin 43:755, 1985.
73. Urist MR, Sato K, Brownwell A, et al: Human bone morphogenetic protein (hBMP). Proc Soc Exp Biol Med 173:194-199,1983.
74. Wagner H: Operative lengthening of the femur. Clin Orthop 136:125-142,1978.
75. Wasserstein I: Twenty-five years experience with lengthening of shortened lower extremities using cylindrical allografts. Clin Orthop 250: 150-153,1990,
76. Westin GW: Femoral lengthening using a periosteal sleeve. J Bone Joint Surg 49A:836-854, 1967.1
77. Winnier G, Blessing M, Labosky PA, Hogan BL: Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes . Dev 9:2105-2116,1995.
78. Yasko AW, Lane JM, Femminger EJ, et al: The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographie, histological, and biochemical study in rats. J Bone Joint Surg 74A: 659-670,1992.
79. Zhaol GQ, Deng K, Labosky PA, Liaw L, Hogan BL: The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes Dev 10: 1657-1669,1996.